Secondary analysis of the TEAYS crossover RCT in 35 patients with phlebolymphoedema: a nonpneumatic compression device gave greater 90-day limb volume reduction than an advanced pneumatic device (424.5 vs 50.8 mL, P=0.0085), better quality of life and adherence (81% vs 49%).
Secondary analysisn = 35
Berland et al. Use of a Portable, Nonpneumatic Active Compression Device in Treatment of Phlebolymphedema: A TEAYS Subanalysis